 |
immune globulin infusion 10% (human) with recombinant human hyaluronidase) |
|---|---|
| Trade Name | |
| Orphan Indication | Chronic inflammatory demyelinating polyneuropathy |
| USA Market Approval | USA |
| USA Designation Date | 2016-03-31 00:00:00 |
| Sponsor | Baxalta US, Inc.;1 Baxter Way;Westlake Village, California, 91362 |
